|
BioNTech
pfizer biontech bnt16b2b2 ![]() Pfizer Biontech Bnt16b2b2, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pfizer+biontech+bnt16b2b2/pfizer+biontech+bnt16b2b2/pmc09111803-17-33-32 Average 90 stars, based on 1 article reviews
pfizer biontech bnt16b2b2 - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Dermatologic Therapy
Article Title: SARS‐CoV‐2 vaccination‐induced cutaneous vasculitis: Report of two new cases and literature review
doi: 10.1111/dth.15458
Figure Lengend Snippet: (A) A case of a 17‐year‐old female with IgA‐vasculitis 10 days after the first dose of Pfizer‐BioNTech BNT16B2b2 mRNA vaccine. (B) A case of 48‐year‐old man with LCV 4 days after the second dose of Pfizer‐BioNTech BNT16B2b2 mRNA vaccine
Article Snippet: Nastroet al., 2021 , 84/M , Palpable purpura on the legs , Leukocytoclastic vasculitis , 2 days , 2 weeks , First dose , Recovery , Systemic antihistamine and local steroid ,
Techniques:
Journal: Dermatologic Therapy
Article Title: SARS‐CoV‐2 vaccination‐induced cutaneous vasculitis: Report of two new cases and literature review
doi: 10.1111/dth.15458
Figure Lengend Snippet: Cutaneous vasculitis reports related to SARS‐CoV‐2 vaccine in the literature, and two new cases
Article Snippet: Nastroet al., 2021 , 84/M , Palpable purpura on the legs , Leukocytoclastic vasculitis , 2 days , 2 weeks , First dose , Recovery , Systemic antihistamine and local steroid ,
Techniques: Histopathology